Lupus Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are 18 years old or older when you sign up for the study.
• You have been diagnosed with Systemic Lupus Erythematosus (SLE, or lupus) based on recognised 2019 medical guidelines.
• Your doctor has decided to prescribe you a medication called anifrolumab for your lupus for the first time, following the approved guidelines in your country.
• Your doctor must have already decided to prescribe anifrolumab before any conversation about joining this study takes place.
• If you live in a country where treatment funding needs individual approval, that approval must be in place before you can join.
• You have agreed to take part in the study by signing a consent form.
• You are willing and able to attend all required study visits and complete all required assessments.

Who may not be able to join:

• You are currently taking part in an early access or compassionate use programme for anifrolumab, or you are already in another clinical trial testing an experimental treatment.
• You have previously received anifrolumab as part of a clinical trial or an early access programme.
• You have been diagnosed with a serious or rapidly worsening form of lupus kidney disease requiring intensive treatment, a specific type of lupus kidney disease called isolated Class V lupus nephritis, or active severe or unstable lupus affecting your brain or mental health (confirm with trial site).
• You have any other condition that, in your doctor's opinion, would make it difficult for you to understand the consent form or complete the study questionnaires.

Important: Always verify eligibility with the trial site directly before applying.